BRISBANE, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today reported its business highlights and financial results for the fourth quarter and full year ended December 31, 2024.
Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Seeking Alpha / 6 hours ago 1 Views
Comments